Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1391053-27-2 | 5-(1-tert-Butyloxycarbonyl-2,3-dihydro-1H-indol-5-yl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C20H23N5O2 |
| 1391053-30-7 | 3,5,6-Trichloro-8-quinolinecarboxylic Acid | C10H4ClNO2 |
| 1391053-45-4 | Ketorolac EP Impurity D | C16H15NO4 |
| 1391053-48-7 | 4-Amino-2-ethynylphenol | C8H7NO |
| 1391053-50-1 | Oxymetazoline EP Impurity A | C16H27ClN2O2 |
| 1391053-53-4 | Defluoro Prasugrel Hydrochloride | C20H22ClNO3S |
| 1391053-54-5 | rac 6-Bromo Phenylephrine Hydrochloride | C9H13BrClNO2 |
| 1391053-55-6 | Domperidone Impurity F | C37H42Cl2N8O3 |
| 1391053-56-7 | 2-[4-[2-(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethanol | C19H23ClN2O |
| 1391053-63-6 | (alphaS,deltaR)-rel-4-Fluoro-alpha-[(R)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-delta-hydroxybenzenepentanoic acid | C24H23F2NO4 |
| 1391053-78-3 | Desfluoro Fluvoxketone | C13H16F2O2 |
| 1391053-79-4 | 3,6-Dibromo-o-anisidine | C7H7Br2NO |
| 1391053-82-9 | O-Desethyl-O-propyl Methisosildenafil | C24H34N6O4S |
| 1391053-90-9 | 3-Isopropylphenyl 4-Propylphenyl Phenyl Phosphate | C24H27O4P |
| 1391053-95-4 | Isobutyl sildenafil | C23H32N6O4S |
| 1391053-98-7 | p-Fluoro Prasugrel Hydrochloride | C20H21ClFNO3S |
| 1391054-00-4 | Hydroxy Chlorodenafil | C19H23ClN4O3 |
| 1391054-02-6 | 4-Amino-5-hexenoic acid hydrochloride (1:1) | C6H11NO2.HCl |
| 1391054-09-3 | (R)-2-Bromo Phenylephrine Hydrochloride | C9H13BrClNO2 |
| 1391054-12-8 | N3-Methanethiosulfonylmethyl Lumiflavin | C15H16N4O4S2 |
| 1391054-15-1 | 1,2,3,4-Tetrahydro-7-(2-methylpropyl)-1-[4-(2-methylpropyl)phenyl]-1,4-naphthalenedicarboxylic acid | C26H32O4 |
| 1391054-22-0 | Amisulpride EP Impurity H | C18H29N3O4S |
| 1391054-30-0 | Nevirapine Dimer | C30H26N8O2 |
| 1391054-31-1 | N-Boc-piperazine-13C4 | C513C4H18N2O2 |
| 1391054-36-6 | rac 4-Bromo Phenylephrine Hydrochloride | C9H13BrClNO2 |
| 1391054-37-7 | 1-Cyclopropyl-2-(2-fluorophenyl)-1,2-ethanedione | C11H9FO2 |
| 1391054-40-2 | 3-De(hydroxymethyl)-3-methyl Salmeterol | C25H37NO3 |
| 1391054-51-5 | 6-Amino-3,7-dichloro-8-quinolinecarboxylic Acid | C10H6Cl2N2O2 |
| 1391054-68-4 | 4’-Deoxy-2’-hydroxy Probucol | C31H48O2S2 |
| 1391054-73-1 | 3-Des[4-(2-Piperidinyl)ethoxy]benzoyl-7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene | C28H27NO4S |
| 1391062-29-5 | (3S)-5-Oxo-3-morpholinecarboxylic Acid 1,1-Dimethylethyl Ester | C9H15NO4 |
| 1391062-34-2 | 2-Hydroxy-4'-[(2-pyridinylamino)sulfonyl]-5-[2-[4-[(2-pyridinylamino)sulfonyl]phenyl]diazenyl][1,1'-biphenyl]-3-carboxylic acid | C29H22N6O7S2 |
| 1391062-35-3 | 4-[4-Hydroxy-3-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenylphenyl]diazenyl-N-pyridin-2-ylbenzenesulfonamide | C28H22N8O5S2 |
| 1391062-37-5 | 5-[2-[4',5-Bis[(2-pyridinylamino)sulfonyl][1,1'-biphenyl]-2-yl]diazenyl]-2-hydroxybenzoic acid | C29H22N6O7S2 |
| 1391062-45-5 | N-Hydroxymethyl Rizatriptan Fumarate | C20H25N5O5 |
| 1391062-49-9 | 2-Hydroxy-3,5-bis[2-[4-[(2-pyridinylamino)sulfonyl]phenyl]diazenyl]benzoic acid | C29H22N8O7S2 |
| 1391067-95-0 | (R)-6-Bromo Phenylephrine Hydrochloride | C9H13BrClNO2 |
| 1391068-15-7 | (R)-4-Bromo Phenylephrine Hydrochloride | C9H13BrClNO2 |
| 1391068-16-8 | (2R)-2-Hydroxyglutaric Acid Octyl Ester Sodium Salt | C13H23NaO5 |
| 1391068-19-1 | Carbocisteine-13C3 | C213C3H9NO4S |
| 1391068-25-9 | N-[(2S)-3-Amino-2-hydroxypropyl]-N-[3-fluoro-4-(4-morpholinyl)phenyl]acetamide hydrochloride (1:1) | C15H22FN3O3.HCl |
| 1391068-26-0 | Folic Acid EP Impurity E | C26H24N12O7 |
| 1391072-73-3 | 6-(Methylsulfanyl)-1,2,3,4-tetrahydroquinoline | C10H13NS |
| 1391080-40-2 | Darifenacin N-Oxide Impurity | C28H30N2O3 |
| 1391194-39-0 | Prasugrel Impurity II | C20H20FNO3S |
| 1391194-45-8 | Prasugrel Impurity I | C20H21NO3S |
| 1391194-50-5 | Prasugrel Impurity III | C20H20FNO3S |
| 1391274-29-5 | 7-(Methylsulfanyl)-1,2,3,4-tetrahydroquinoline | C10H13NS |
| 1391291-94-3 | 8-Methanesulfonyl-1,2,3,4-tetrahydroquinoline | C10H13NO2S |
| 1391393-86-4 | 3-O-Methyl-L-DOPA 4-Sulfate | C10H13NO7S |